Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

19.07
Delayed Data
As of May 04
 +0.89 / +4.90%
Today’s Change
9.38
Today|||52-Week Range
20.43
+58.39%
Year-to-Date

Today’s Trading

Previous close18.18
Today’s open18.46
Day’s range-- - --
Volume1,010,785
Average volume (3 months)968,841
Market cap$1.1B
Dividend yield--
Data as of 05/04/2015

Growth & Valuation

Earnings growth (last year)+10.33%
Earnings growth (this year)+80.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+47.33%
P/E ratioNM
Price/Sales11.91
Price/Book4.80

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.76+1.88%
CHRSCoherus Biosciences ...-0.07-0.30%
RLYPRelypsa Inc+0.76+2.51%
RTRXRetrophin Inc+0.46+2.02%
Data as of 05/04/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$52.3M
Annual profit (last year)-$98.6M
Net profit margin-188.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Financial Officer &
Senior Vice President
Richard P. Shea
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers